rs2640909

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_001377275.1(PER3):​c.3110T>C​(p.Met1037Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.159 in 1,157,842 control chromosomes in the GnomAD database, including 30,389 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M1037V) has been classified as Uncertain significance.

Frequency

Genomes: š‘“ 0.23 ( 4680 hom., cov: 30)
Exomes š‘“: 0.15 ( 25709 hom. )

Consequence

PER3
NM_001377275.1 missense

Scores

1
17

Clinical Significance

Likely benign no assertion criteria provided B:1

Conservation

PhyloP100: -0.207

Publications

54 publications found
Variant links:
Genes affected
PER3 (HGNC:8847): (period circadian regulator 3) This gene is a member of the Period family of genes and is expressed in a circadian pattern in the suprachiasmatic nucleus, the primary circadian pacemaker in the mammalian brain. Genes in this family encode components of the circadian rhythms of locomotor activity, metabolism, and behavior. This gene is upregulated by CLOCK/ARNTL heterodimers but then represses this upregulation in a feedback loop using PER/CRY heterodimers to interact with CLOCK/ARNTL. Polymorphisms in this gene have been linked to sleep disorders. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2014]
PER3 Gene-Disease associations (from GenCC):
  • advanced sleep phase syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0044260025).
BP6
Variant 1-7830057-T-C is Benign according to our data. Variant chr1-7830057-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 3059597.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.288 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PER3NM_001377275.1 linkc.3110T>C p.Met1037Thr missense_variant Exon 19 of 22 ENST00000377532.8 NP_001364204.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PER3ENST00000377532.8 linkc.3110T>C p.Met1037Thr missense_variant Exon 19 of 22 1 NM_001377275.1 ENSP00000366755.3 P56645-2
PER3ENST00000361923.2 linkc.3083T>C p.Met1028Thr missense_variant Exon 18 of 21 1 ENSP00000355031.2 P56645-1
PER3ENST00000614998.4 linkc.3053T>C p.Met1018Thr missense_variant Exon 20 of 23 1 ENSP00000479223.1 A0A087WV69
PER3ENST00000613533.4 linkc.3110T>C p.Met1037Thr missense_variant Exon 19 of 22 5 ENSP00000482093.1 P56645-2

Frequencies

GnomAD3 genomes
AF:
0.232
AC:
35026
AN:
150816
Hom.:
4678
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.116
Gnomad AMI
AF:
0.231
Gnomad AMR
AF:
0.260
Gnomad ASJ
AF:
0.298
Gnomad EAS
AF:
0.0560
Gnomad SAS
AF:
0.263
Gnomad FIN
AF:
0.314
Gnomad MID
AF:
0.210
Gnomad NFE
AF:
0.291
Gnomad OTH
AF:
0.234
GnomAD2 exomes
AF:
0.139
AC:
25208
AN:
181200
AF XY:
0.135
show subpopulations
Gnomad AFR exome
AF:
0.0571
Gnomad AMR exome
AF:
0.137
Gnomad ASJ exome
AF:
0.142
Gnomad EAS exome
AF:
0.0246
Gnomad FIN exome
AF:
0.232
Gnomad NFE exome
AF:
0.161
Gnomad OTH exome
AF:
0.165
GnomAD4 exome
AF:
0.148
AC:
148940
AN:
1006908
Hom.:
25709
Cov.:
35
AF XY:
0.156
AC XY:
79573
AN XY:
509760
show subpopulations
African (AFR)
AF:
0.0560
AC:
1634
AN:
29174
American (AMR)
AF:
0.164
AC:
5636
AN:
34364
Ashkenazi Jewish (ASJ)
AF:
0.224
AC:
4565
AN:
20356
East Asian (EAS)
AF:
0.0721
AC:
2802
AN:
38872
South Asian (SAS)
AF:
0.200
AC:
13854
AN:
69432
European-Finnish (FIN)
AF:
0.299
AC:
14836
AN:
49608
Middle Eastern (MID)
AF:
0.192
AC:
938
AN:
4876
European-Non Finnish (NFE)
AF:
0.136
AC:
97154
AN:
714078
Other (OTH)
AF:
0.163
AC:
7521
AN:
46148
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
6573
13147
19720
26294
32867
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
668
1336
2004
2672
3340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.232
AC:
35055
AN:
150934
Hom.:
4680
Cov.:
30
AF XY:
0.233
AC XY:
17195
AN XY:
73722
show subpopulations
African (AFR)
AF:
0.116
AC:
4748
AN:
40912
American (AMR)
AF:
0.261
AC:
3963
AN:
15212
Ashkenazi Jewish (ASJ)
AF:
0.298
AC:
1032
AN:
3458
East Asian (EAS)
AF:
0.0559
AC:
286
AN:
5112
South Asian (SAS)
AF:
0.264
AC:
1263
AN:
4788
European-Finnish (FIN)
AF:
0.314
AC:
3297
AN:
10492
Middle Eastern (MID)
AF:
0.214
AC:
63
AN:
294
European-Non Finnish (NFE)
AF:
0.291
AC:
19707
AN:
67666
Other (OTH)
AF:
0.233
AC:
487
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1284
2567
3851
5134
6418
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
378
756
1134
1512
1890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.271
Hom.:
5722
Bravo
AF:
0.223
TwinsUK
AF:
0.287
AC:
1065
ALSPAC
AF:
0.309
AC:
1189
ESP6500AA
AF:
0.127
AC:
560
ESP6500EA
AF:
0.295
AC:
2539
ExAC
AF:
0.253
AC:
30691
Asia WGS
AF:
0.0780
AC:
257
AN:
3292

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

PER3-related disorder Benign:1
Feb 26, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.067
BayesDel_addAF
Benign
-0.80
T
BayesDel_noAF
Benign
-0.78
CADD
Benign
0.045
DANN
Benign
0.39
DEOGEN2
Benign
0.0082
.;T;.;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.7
FATHMM_MKL
Benign
0.0012
N
LIST_S2
Benign
0.28
T;T;.;T
MetaRNN
Benign
0.0044
T;T;T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
0.0
.;.;.;N
PhyloP100
-0.21
PrimateAI
Uncertain
0.49
T
PROVEAN
Benign
0.76
.;.;N;N
REVEL
Benign
0.011
Sift
Benign
0.20
.;.;T;T
Sift4G
Benign
0.94
T;T;T;T
Polyphen
0.017
B;.;B;B
Vest4
0.15
MPC
0.10
ClinPred
0.0045
T
GERP RS
-1.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.016
gMVP
0.20
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2640909; hg19: chr1-7890117; COSMIC: COSV62704459; COSMIC: COSV62704459; API